| Scorecard |
|---|
|
5 / 5 Stars
|
|
Lipper
5
5
3
3
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
B+
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 13.09 | 13.09 |
| Stocks | 0.0 | 0.0 |
| Bonds | 0.0 | 0.0 |
| Other | 2.96 | 2.96 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 83.95 | 83.95 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 12.31.2012
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 12.31.2012
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| DCC PLC | DCC | --- | 3.48 |
| Aryzta AG | ARZTF | 29.4 | 2.59 |
| Prosafe SE | PRS | --- | 2.45 |
| Yazicilar Holding A.S. | YAZIC | --- | 2.17 |
| Origin Enterprises PLC | ORENF | --- | 2.07 |
| MorphoSys AG | MOR | --- | 2.06 |
| United Drug PLC | UDG | --- | 1.92 |
| CPL Resources PLC | DQ5 | --- | 1.9 |
| Mediq N.V. | MEDIQ | --- | 1.81 |
| Total Produce PLC | T7O | --- | 1.79 |
